Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil and butter on the susceptibility of low density lipoprotein to oxidative modification in men

European Journal of Clinical Nutrition

Volumn 50, Issue 6, 1996, Pages 364-370

  Halvorsen, B ^a   Almendingen, K ^a   Nenseter, M S ^a   Pedersen, J I ^a,b   Christiansen, E N ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Akershus College   (Norway)

Author keywords

Butter; Lipid peroxidation; Low density lipoprotein; Oxidative modification; Partially hydrogenated fish oil; Partially hydrogenated soybean oil

Indexed keywords

ALPHA TOCOPHEROL; FATTY ACID; FISH OIL; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; SOYBEAN OIL;

ADULT; ARTICLE; BUTTER; CALORIC INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN EXPERIMENT; HYDROGENATION; LIPID PEROXIDATION; MACROPHAGE; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADULT; BUTTER; COPPER; CROSS-OVER STUDIES; DIETARY FATS; ENERGY INTAKE; FISH OILS; HUMANS; HYDROGENATION; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MACROPHAGES; MALE; OXIDATION-REDUCTION; SOYBEAN OIL; VITAMIN E;

GLYCINE MAX;

EID: 0029977102     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Almendingen K, Jordal O, Kierulf P, Sandstad B & Pedersen JI (1995): Effects of partially hydrogenated fish oil and partially hydrogenated soybean oil and butter on serum lipoproteins in men. J.Lipid Res.36, 1370-1384.
2. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC & Krauss RM (1988): Low density lipoprotein subclass patterns and risk of myocardial infarction. J. Am. Med. Assoc. 260, 1917-1921.
3. Bonanome A, Pagnan A, Biffanti S, Opportune A, Sorgato F, Dorella M, Maiorino M & Ursini F (1992): Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification. Arterioscler. Tkromb. 12, 529-533.
4. Boyd HC, Gown AM, Wolfbauer G & Chait A (1989): Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am. J. Pathoi 135, 815-825.
5. Brussard JH, Katan MB, Groot PHE, Havekes LM & Hautwast JGAJ (1982): Serum lipoproteins of healthy persons fed a low-fat diet or a polyunsaturated fat diet for three month. A comparison of two cholesterol-lowering diets. Atherosclerosis 42, 205-219.
6. Buege JA & Aust SD (1978): Microsomal lipid peroxidation. Methods Enzymol. 52, 302-310.
7. Campos H, Blijlevens E, McNamara JR, Ordvas JM, Posner Bm, Wilson PWF, Castelli WP & Schaefer EJ (1992): LDL particle size distribution: results from the Framingham Offspring Study. Arterioscler. Thromb. 12, 1410-1418.
8. Cathcart MK, McNally AK, Morel DW & Chisolm GM (1989): Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin. J. Immunol. 142, 1963-1969.
9. Chait A, Brazg RL, Tribble DL & Krauss RM (1993): Susceptibility of small, dense, low density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am. J. Med. 94, 350-356.
10. deGraaf J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendriks JCM & Stalenhoef AFH (1991): Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Atherosclerosis 11, 298-306.
11. De Leenheer AP, De Bevere VORC & Claeys AE (1979): Measurement of a, β and γ-tocopherol in serum by liquid chromatography. Clin. Chem. 25, 425-428.
12. Dreon DM, Fernstrom HA, Miler B & Krauss RM (1994): Lowdensity lipoprotein subclass patterns and lipoprotein response to a reduced-fat diet in men. FASEBJ. 8, 121-126.
13. Emken EA, Adlof R, Rohwedder WK & Gulley RM (1989): Incorporation of trans-8 and cis 8-octadecenoic acid isomers in human plasma and lipoprotein lipids. Lipids 24, 61-69.
14. Esterbauer H, Striegl G, Punl H, Rotheneder M (1989): Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad. Res. Commun. 6, 67-75.
15. Esterbauer H, Gebicki J, Puni H & Jürgens G (1992): The role of lipid proxidation and antioxidants in oxidative modification of LDL. Free Rad. Biol. Med. 13, 341-390.
16. FASEB Report (1985): Health aspects of dietary Irans fatty acids, August 1985, ed. FR Senti. Bethesda MD : Federation of American Societies of Experimental Biology.
17. Frankel EN, Parks EJ, Xu R, Schneeman BO, Davis PA & German JB (1994): Effect of n-3 fatty acid-rich fish oil supplementation on the oxidation of low density lipoproteins. Lipids 29, 233-236.
18. Haberland ME, Fong D & Cheng L (1988): Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 241, 215-218.
19. Harats D, Dabach Y, Hollander G, Ben-Naim M, Schwartz R, Berry EM, Stein O & Stein Y (1991): Fish oil ingestion in smokers and nonsmokers enhanced peroxidation of plasma lipoproteins. Atherosclerosis 90, 127-139.
20. Havel RJ, Eder HA & Bragdon JH (1955): The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34, 1345-1353.
21. Hunter JE & Applewhite TH (1991): Reassessment of trans fatty acid availability in the US diet. Am. J. Clin. Nutr. 54, 363-369.
22. Lussier-Cacan S, Dubreuil-Quidoz S, Roederer G, Leboeuf N, Boulet L, deLangavant GC & Davignon J (1993): Influence of probucol on enhanced LDL oxidation after fish oil treatment of hypertriglyceridemic patients Arterioscler. Thromb. 13, 1790-1779.
23. Mensink RP & Katan MB (1987): Effect of monounsaturated fatty acids vs complex carbohydrates on high-density lipoprotein in healthy men and women. Lancet 1, 122-125.
24. Nenseter MS, Rustan AC, Lund-Katz S, Sayland E, Maelandsmo G, Phillips MC & Drevon CA (1992): Effect of dietary supplementation with n-3 polyunsaturated fatty acids on physical properties and metabolism of low density lipoprotein in humans. Arterioscler. Thromb. 12, 369-379.
25. Nestel P, Noakes M, Belling B, McArthur R, Clifton P, Janus E & Abbey M (1992): Plasma lipoprotein lipid and Lp[a] changes with substitution of eladic acid for oleic acid in the diet. J. Lipid Res. 33, 1029-1036.
26. Noble RP (1968): Electrophoretic separation of plasma lipoproteins in agarose gel. J. Lipid Res. 52, 302-310.
27. Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gurtner GC, Socher SA, Butler SW, Parthasarathy S, Carew TE, Steinberg D & Witztum JL (1989): Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natn. Acad. Sci. U.S.A. 86, 1372-1376.
28. Pittman RC, Carew TE, Glass CK, Green SR, Taylor CA & Attie AD (1983): A radioiodinated, intracellulary trapped ligand for determinating the sites of plasma protein degradation in vivo. Biochem. J. 34, 1345-1353.
29. Quinn MT, Parthasarathy S, Fong LG & Steinberg D (1987): Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc. Natn. Acad. Sci. U.S.A 84, 2995-2998.
30. Reaven PD, Parthasarathy S, Grasse BJ, Miller E, Almazan F, Mattson FH, Khoo JC, Steinberg D & Witztum J (1991): Feasibility of using an oleat-enriched diet to reduce the susceptibility of low density lipoprotein to oxidative modification in humans. Am. J. Clin. Nutr. 54, 701-706.
31. Reaven PD, Parthasarathy S, Grasse BJ, Miller E, Steinberg D & Witztum JL (1993): Effects of oleat-enriched and linoleate-enriched diets on the susceptibility of low density lipoprotein to oxidative modification in hypercholesterolemic subjects. J. Clin. Invest. 91, 668-676.
32. Reaven PD, Grasse BJ & Tribble DL (1994): Effects of linoleateenriched and oleate-enriched diets in combination with αtocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans. Arterioscler. Thromb. 14, 557-566.
33. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ & Klenk DC (1985): Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85.
34. Steinbrecher UP, Witztum JL, Parthasarathy S & Steinberg D (1987): Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Arteriosclerosis 7, 135-143.
35. Steinbrecher UP (1987): Oxidation of human low density lipoprotein results in derivatization of lysine residues of apoprotein B by lipids peroxide decomposition products. J. Biol. Chem. 262, 3603-3608.
36. Tribble DL, Holl LG, Woos PD & Krauss RM (1992): Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 93, 189-199.
37. Tribble DL, Krauss RM, Lansberg MG, Thiel PM & van den Berg JJM (1995): Greater oxidative susceptibility of the surface mono-layer in small dense LDL may contribute to differences in copperinduced oxidation among LDL density subfractions. J. Lipid Res. 36, 662-671.
38. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler SW, Witztum JL & Steinberg D (1989): Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84, 1086-1095.
39. Witztum JL & Steinberg D (1991) Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88, 1785-1792.
40. Willett WC, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Rosner BA, Sampson LA & Hennekens CH (1993): Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 341, 581-585.